Pharmacy providers resources

Alberta pharmacies

Compensation guide

Reference Guide for the 2024-2025 Alberta Influenza Immunization Program

AlbertaQuits Pharmacy Claims Reference Guide

Critical Supply Product List (PDF) | (Excel)

Nutritional Product, Package Size, and UPC Listing (PDF) | (Excel)

---

Alberta Blue Cross^® Guide to Step Therapy

Alberta Blue Cross^® Standard Maximum Allowable Cost (MAC) Drugs and Reference Price Listing

ASEBP TARP Drugs and Reference Price Listing

ASEBP member FAQs regarding TARP policy

Frequent Dispensing Policy Q&As

Maintenance Medication Program Drug Listing

Pharmacist Prescriber Special Authorization Registration Form

MAC Pricing Categories

Calcium Channel Blockers details

Statin details

ACE Inhibitors details

Patient information sheet

Healthcare Professionals Guide – November 1, 2025

Patient Information Sheet – December 1, 2025

Patient Supports – November 1, 2025

Addition of tocilizumab biosimilars – all adult patients on Actemra must switch by June 30, 2026 – July 1, 2025

Addition of omalizumab biosimilar – all adult patients on Xolair must switch by June 1, 2026 – December 1, 2025

Summary table of drugs in Biosimilar Initiative – December 1, 2025

Resources

Biosimilar Initiative Patient List Request Form

Biosimilar Initiative Exception Request Form

GNWT Pharmacy Drug Reference Guide

GNWT Pharmacy Medical Supplies Reference Guide

Biosimilars Initiative Support: Patient List Request Form

WCB-Alberta Direct Bill FAQ

IPTP Reference Guide